The $3million will kick start the trials then retail investors will come in more IMO. The past PR's regarding money from Northstar, Vitalmex, etc. never went through I don't believe per the SEC documents.
NVLX is a good example like you say, but Bioheart has approved phase 3 trials for Heart failure! This is really big IMO.